Universidad San Jorge
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lucas, María D López
Enhancer, NCT05809830: Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas

Recruiting
1/2
152
Europe
LB-100 plus Doxorrubicin, Doxorubicin
Grupo Espanol de Investigacion en Sarcomas
Advanced Soft-tissue Sarcoma
06/25
05/26
Fernández, Luis
BioIBD, NCT03885713: Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

Recruiting
4
180
Europe
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
12/24
12/24
NCT03763604: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Approved for marketing
N/A
Europe, Canada, RoW
Abemaciclib, LY2835219
Eli Lilly and Company
Metastatic Breast Cancer
 
 
NEOVAS, NCT05823519: Neck Evolution With Ovation in Spain

Recruiting
N/A
120
Europe
Endologix Ovation Alto Endograft
DGM Vascular, Hospital Universitario Central de Asturias
Abdominal Aortic Aneurysm
01/24
01/27
Sola, Luis Fernández
NCT04693494: Effectiveness of a Training Program for Parents of Babies in Their First Year of Life to Achieve Motor Milestones

Completed
N/A
82
Europe
Training program
Universidad San Jorge
Term, Healthy, Motor Delay, Development, Infant
12/20
01/23
Díez, Beatriz Cano
NCT04693494: Effectiveness of a Training Program for Parents of Babies in Their First Year of Life to Achieve Motor Milestones

Completed
N/A
82
Europe
Training program
Universidad San Jorge
Term, Healthy, Motor Delay, Development, Infant
12/20
01/23

Download Options